These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 27236558)
1. Phosphatases: Their Roles in Cancer and Their Chemical Modulators. Fontanillo M; Köhn M Adv Exp Med Biol; 2016; 917():209-40. PubMed ID: 27236558 [TBL] [Abstract][Full Text] [Related]
2. Rising of phosphatases as targets of cancer treatment. Heneberg P Anticancer Agents Med Chem; 2011 Jan; 11(1):1-3. PubMed ID: 21395544 [No Abstract] [Full Text] [Related]
3. [Kinases and phosphatases: key enzymes in targeted cancer therapy]. Schulze M; Gohla A Dtsch Med Wochenschr; 2013 Mar; 138(9):437-40. PubMed ID: 23423940 [No Abstract] [Full Text] [Related]
4. Protein tyrosine phosphatases in cancer: friends and foes! Labbé DP; Hardy S; Tremblay ML Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721 [TBL] [Abstract][Full Text] [Related]
5. Meeting Report Europhosphatase 2015: Phosphatases as Drug Targets in Cancer. Hoekstra E; Peppelenbosch MP; Fuhler GM Cancer Res; 2016 Jan; 76(2):193-6. PubMed ID: 27309387 [TBL] [Abstract][Full Text] [Related]
6. The druggability of intracellular nucleotide-degrading enzymes. Rampazzo C; Tozzi MG; Dumontet C; Jordheim LP Cancer Chemother Pharmacol; 2016 May; 77(5):883-93. PubMed ID: 26614508 [TBL] [Abstract][Full Text] [Related]
8. Phosphatases as targets for cancer treatment. Lazo JS; Wipf P Curr Opin Investig Drugs; 2009 Dec; 10(12):1297-304. PubMed ID: 19943201 [TBL] [Abstract][Full Text] [Related]
9. Protein phosphatase 2A as a potential target for anticancer therapy. Kalev P; Sablina AA Anticancer Agents Med Chem; 2011 Jan; 11(1):38-46. PubMed ID: 21288198 [TBL] [Abstract][Full Text] [Related]
10. De novo DNA methyltransferases: oncogenes, tumor suppressors, or both? Fernandez AF; Huidobro C; Fraga MF Trends Genet; 2012 Oct; 28(10):474-9. PubMed ID: 22704242 [TBL] [Abstract][Full Text] [Related]
11. Protein kinases and phosphatases as therapeutic targets in cancer. Ventura JJ; Nebreda AR Clin Transl Oncol; 2006 Mar; 8(3):153-60. PubMed ID: 16648114 [TBL] [Abstract][Full Text] [Related]
12. Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents. Brautigan DL; Farrington C; Narla G Clin Sci (Lond); 2021 Jul; 135(13):1545-1556. PubMed ID: 34192314 [TBL] [Abstract][Full Text] [Related]
13. Regulatory cascades of protein phosphatases: implications for cancer treatment. Jailkhani N; Chaudhri VK; Rao KV Anticancer Agents Med Chem; 2011 Jan; 11(1):64-77. PubMed ID: 21214508 [TBL] [Abstract][Full Text] [Related]
14. A small molecule inhibitor of p53-inducible protein phosphatase PPM1D. Yagi H; Chuman Y; Kozakai Y; Imagawa T; Takahashi Y; Yoshimura F; Tanino K; Sakaguchi K Bioorg Med Chem Lett; 2012 Jan; 22(1):729-32. PubMed ID: 22115592 [TBL] [Abstract][Full Text] [Related]
15. The role and target potential of protein tyrosine phosphatases in cancer. Yi T; Lindner D Curr Oncol Rep; 2008 Mar; 10(2):114-21. PubMed ID: 18377824 [TBL] [Abstract][Full Text] [Related]
16. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. MacKeigan JP; Murphy LO; Blenis J Nat Cell Biol; 2005 Jun; 7(6):591-600. PubMed ID: 15864305 [TBL] [Abstract][Full Text] [Related]
17. Day of the dead: pseudokinases and pseudophosphatases in physiology and disease. Reiterer V; Eyers PA; Farhan H Trends Cell Biol; 2014 Sep; 24(9):489-505. PubMed ID: 24818526 [TBL] [Abstract][Full Text] [Related]
18. Elucidating human phosphatase-substrate networks. Li X; Wilmanns M; Thornton J; Köhn M Sci Signal; 2013 May; 6(275):rs10. PubMed ID: 23674824 [TBL] [Abstract][Full Text] [Related]
19. The road less travelled: taming phosphatases. Widlanski TS; Myers JK; Stec B; Holtz KM; Kantrowitz ER Chem Biol; 1997 Jul; 4(7):489-92. PubMed ID: 9263635 [TBL] [Abstract][Full Text] [Related]